Breaking News, Collaborations & Alliances

PAREXEL, Proteome Sciences Enter Biomarker Alliance

PAREXEL International and Proteome Sciences have formed an alliance focused on enhancing PAREXEL's biomarker capabilities for early phase clinical development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL International and Proteome Sciences have formed an alliance focused on enhancing PAREXEL’s biomarker capabilities for early phase clinical development. PAREXEL will use Proteome Sciences’ PS Biomarker Services protein and peptide biomarker capabilities to support earlier assessments of new compounds in development through biomarker discovery and qualification within clinical trials The alliance allows PAREXEL to offer mass spectrometric and pharmacokinetic assays for protein ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters